Minnesota Epilepsy Group

Top Publications

Top Publications Authored or Co-Authored in "Minnesota Epilepsy Group"

• Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebo-controlled trial

  The Lancet, Volume 381, No. 9869, Year 2013, Citations 710
• Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial

  The Lancet, Volume 381, No. 9861, Year 2013, Citations 654
• Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

  Pediatric Neurology, Volume 123, Year 2021, Citations 220
• Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

  The Lancet Oncology, Volume 15, No. 13, Year 2014, Citations 149
• Long-term use of everolimus in patients with tuberous sclerosis complex: Final results from the EXIST-1 study

  PLoS ONE, Volume 11, No. 6, Article e0158476, Year 2016, Citations 146